Accuray(US:ARAY) Prnewswire·2024-06-27 11:35Core Insights - Accuray Incorporated has announced that Heidelberg University Hospital has selected its Radixact System, which includes ClearRT, Synchrony, and VOLO Ultra Optimizer, to enhance cancer treatment delivery [1][4] - The Radixact System is designed to improve precision and efficiency in treating a wide range of cancer cases, replacing the older TomoTherapy System [1][3] - Heidelberg University Hospital is recognized as a global leader in cancer care and has been named one of the best hospitals in the world by Newsweek magazine [4] Company Overview - Accuray is committed to advancing radiation therapy technology to improve patient outcomes and expand treatment options for complex cases [5] - The company focuses on continuous innovation in radiation therapy for oncology and neuro-radiosurgery, partnering with clinicians to enhance patient care [5] Technology and Innovation - The Radixact System integrates advanced technologies such as ClearRT imaging, Synchrony motion tracking, and VOLO Ultra Optimizer to provide improved workflow, image clarity, and treatment precision [4] - The system allows for the treatment of more patients efficiently, leveraging the benefits of image-guided intensity modulated radiation therapy (IG-IMRT) [3][4]